Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In the rat, fear-potentiated startle (FPS) test animals are first trained to associate brief light presentations with a mild electric footshock and then tested for startle responses to acoustic stimuli, delivered either in darkness (i.e. baseline startle) or after the conditioning stimulus. Following light presentation the magnitude of the startle response is markedly increased, and the test is commonly used to distinguish anxiolytic drug effects (i.e. a reduction in FPS) from non-specific effects such as sedation/muscle relaxation. However, recent studies suggest that the environment in which the animal is trained may also contribute towards the acquisition of a conditioned fear response (i.e. contextual fear conditioning) and that this may elevate startle responses recorded in the dark. In the present study, therefore, we have compared the benzodiazepine/gamma-aminobutyric acid-A receptor agonist chlordiazepoxide with the partial agonists FG 8205 and bretazenil, which are known to have a reduced propensity to produce sedation/myorelaxation, using two different FPS procedures: (i) conditioning and testing in stabilimeter chambers, and (ii) conditioning and testing in different environments. The results show that FPS can be demonstrated in both procedures and that treatment with chlordiazepoxide, FG 8205 or bretazenil dose-dependently attenuates the response. However, animals conditioned and tested in stabilimeter chambers also showed a significant increase in dark-startle amplitudes compared with non-shocked rats, suggesting that this response was elevated by contextual fear conditioning. Furthermore, despite clear differences in side-effect liabilities, FG 8205 and bretazenil significantly reduced dark-startle responses, suggesting that this measure is also sensitive to the anxiolytic effects of benzodiazepines. In contrast, when animals were conditioned and tested in different environments, dark-startle responses were not significantly different from those recorded in non-shocked rats and treatment with FG 8205 or bretazenil had no effect. Thus, conditioning and testing animals in different environments may provide a more effective means of distinguishing anxiolytic from non-specific drug effects in the rat FPS test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar effects have been reported in rodents (Guscott et al, 2000).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Guscott et al, 2000
In the citing paper
“it is possible that rather than simply reflecting a nonspecific side effect, the reduction in startle baseline by diazepam in humans (Baas et al, 2002) and rodents (Guscott et al, 2000) might be caused by an anxiolytic effect on contextual anxiety.”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Guscott et al, 2000
Citations
Cites
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
Modality-Specific Retrograde Amnesia of Fear
Kim, J. J., & Fanselow, M. S. (1992) · Science · doi:10.1126/science.1585183 · Cited by 2,483 · cited 1×
“Knoflach et al., 1993 and were chosen because of their known anxiolytic effects but lower propensity to induce sedationrmuscle relaxation compared with full agonists such as diazepam and chlordiazepoxide ŽTricklebank et al., 1990; Facklam et al., 1992a; Griebel et al., 1996; Haefely et al., 1990;…”
BackgroundNeurotransmission in the rat amygdala related to fear and anxiety
Davis, M., Rainnie, D., & Cassell, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90106-6 · Cited by 771
Fear-potentiated startle: A neural and pharmacological analysis
Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 748 · cited 1×
“Davis, 1992; Davis et al., 1994 , it is perhaps not surprising that chlordiazepoxide, FG 8205 and bretazenil were effective in reducing FPS in both procedures.”
MethodConditioned fear as revealed by magnitude of startle response to an auditory stimulus.
Brown, J. S., Kalish, H. I., & Farber, I. E. (1951) · Journal of Experimental Psychology · doi:10.1037/h0060166 · Cited by 637 · cited 1×
“The rat fear-potentiated startle FPS test was iniŽ .tially devised by Brown et al. 1951 and was based on anecdotal evidence that humans startle more to a loud noise when they are afraid.”
MethodAre different parts of the extended amygdala involved in fear versus anxiety?
Davis, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00288-1 · Cited by 549
Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037//0735-7044.100.6.814 · Cited by 343 · cited 2×
“…of the test is that, within individual animals, drug effects on anxiety i.e., a reduction in FPS, can be distinguished from non-specific effects such as sedation and muscle relaxation, which may also reduce baseline startle Žresponses measured in the dark Davis, 1986; Davis .et al., 1987 .”
BackgroundMcNish, K. A., Gewirtz, J. C., & Davis, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09353.1997 · Cited by 284 · cited 1×
“Indeed, recent studies suggest that contextual FPS is not altered following dorsal hippocampal Ž .lesions McNish et al., 1997 , results that contrast Behavioural Pharmacology 2000, Vol 11 No 6502 with those reported using freezing as the behavioural endpoint and that question the differences in…”
BackgroundNovel anxiolytics that act as partial agonists at benzodiazepine receptors
Haefely, W., Martin, J. R., & Schoch, P. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90126-s · Cited by 276 · cited 3×
“…animals are placed in the same stabilŽimeter chamber both for conditioning typically 10 .lightrshock pairings per day for 2 days and to record the amplitude of the startle reflex during the ŽFPS test Hijzen and Slangen, 1989; Hijzen et al., 1995; Mansbach and Geyer, 1988; Joordens et al., .1996 .”
BackgroundMethodDavis, M. (1979) · Psychopharmacology · doi:10.1007/bf00426027 · Cited by 263
Research works printed but not linked: 6
- Davis, 1986, Behav Neurosci, 100, 814, 10.1037/0735-7044.100.6.814 · DOI · Paper page
- Facklam, 1992, J Pharmacol Exp Ther, 261, 1113
- Facklam, 1992, J Pharmacol Exp Ther, 261, 1106
- Knoflach, 1993, J Pharmacol Exp Ther, 266, 385
- Wafford, 1993, Mol Pharmacol, 44, 437
- Wafford, 1993, Mol Pharmacol, 43, 240
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology
Grillon, C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01665-7 · Cited by 494
“In rats, benzodiazepines reduce fearpotentiated startle to explicit conditioned cues (Davis 1979; Hijzen and Slangen 1989; Hijzen et al 1995; Joordens et al 1998; Guscott et al 2000), but there are no clear-cut results in humans.”
BackgroundResultGrillon, C., Baas, J. M. P., Pine, D. S., Lissek, S., Lawley, M., Ellis, V., & Levine, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.027 · Cited by 157
“This reduction is a result not only of sedation but also of n anxiolytic effect on contextual fear (Guscott et al 2000).”
BackgroundInfluence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety
Martin, J. R., Ballard, T. M., & Higgins, G. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00713-4 · Cited by 151
Benzodiazepines have no effect on fear-potentiated startle in humans
Baas, J., Grillon, C., Böcker, K., Brack, A., Morgan, C., Kenemans, L., & Verbaten, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1011-8 · Cited by 116
Metadata
- Authors
- Guscott, M. R., Cook, G. P., & Bristow, L. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- Guscott, M.R.
- Venue
- Behavioural Pharmacology
- Published
- 2000-09
- Volume
- 11
- Issue
- 6
- Pages
- 495-504
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2315469621
- Cited by
- 33
- References
- 30
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2015: 1 · 2013: 3 · 2012: 1
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- fear-potentiated startle, contextual fear conditioning, benzodiazepines, GABA-A receptor agonists, chlordiazepoxide, bretazenil
- MeSH terms
- Animals, Anticonvulsants, Avoidance Learning, Benzodiazepines, Benzodiazepinones, Chlordiazepoxide, Conditioning, Operant, Electric Stimulation, Fear, Male, Reflex, Startle, Anti-Anxiety Agents, Rats, Sprague-Dawley, GABA Modulators, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists. https://app.cochat.ai/papers/10.1097/00008877-200009000-00006
- The paper
- Guscott, M. R., Cook, G. P., & Bristow, L. J. (2000). Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists. Behavioural Pharmacology. https://doi.org/10.1097/00008877-200009000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.